Business Standard

Brookfield's equity infusion crucial for Indostar Capital in Q1 FY21: CARE

Besides challenges faced by wholesale NBFC in particular, the credit costs (amount to be provided for stressed assets), are likely increase post outbreak of COVID 19

taxes, funds, revenue, audit, income, salary, balance, revenue, receipts, collections
Premium

Abhijit Lele Mumbai
An equity infusion of Rs 1,225 crore by Brookfield Business Partners into Indostar Capital Finance Ltd (ICF) in first quarter of FY21 is crucial to ensure adequate liquidity when NBFC sector is facing challenges in resource mobilization after COVID outbreak.

Rating agency CARE has placed the ratings of Indostar Capital’s ted on credit watch with developing implications. The long-term debt carries “AA-“ rating.

Besides challenges faced by wholesale NBFC in particular, the credit costs (amount to be provided for stressed assets), are likely increase post outbreak of COVID 19. The said equity infusion would be critical for ICF as it

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in